Wire · regulatory
RAPS Convergence: CDRH Stability Faces New Test As Center Begins To Rebuild Depleted Staff
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 18 September 2026 · Fusion42 review
The FDA's Center for Devices and Radiological Health (CDRH) is facing challenges due to depleted staff levels but has begun efforts to rebuild its workforce, impacting regulatory review stability in the US medical device sector.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Regulatory delays will ease as FDA rebuilds CDRH staff, opening opportunities for Medtech founders to accelerate US device approvals ahead of competitors still facing bottlenecks.
◆ Coverage
1 source · 17 Sep 2026
◆ Related on Wire
◆ Topics
Medtechfdacdhrregulatory-staffingus-medtechmedical-devices